FLOW INDUCED COALESCENCE IN POLYMER BLENDS

Abstract. A modified theory of coalescence induced by extensional flow in polymer blends with Newtonian droplets in viscoelastic matrix has been derived. Results of this theory are compared with results of the theory of shear flow induced coalescence. Elasticity of the matrix leads to a decrease in the coalescence probability

Circular consumption and production of electronic devices: an approach to measuring durability, upgradeability, reusability, obsolescence and premature recycling

What is circular consumption of electronics? Is it measurable? Can we set goals or compare with other consumers? A principle of circular economy is durability, prolonging the useful life of products. If we move the principle to the function of consumption, we would have that: circular consumption is to make the most of time resources by ensuring that in the end they are recycled, but never before time or prematurely, but only when they can no longer be used or reused by anyone else. In this article we propose a set of measures, metrics and progress indicators to measure the use of resources that consumers make in their use phase. With these metrics we can identify which consumers are the most circular; those who are able to use the same electronic devices for the longest time, either internally, or by collaborating with external agents so that these devices are reused and recycled properly. We have been able to validate usage performance metrics and premature recycling in the analysis of more than 3,000 desktop and laptop type electronic devices. These devices have been discarded by hundreds of organisations in 2018 and 2019. Finally, we propose the metrics of durability and obsolescence for models and brands of devices, which although it does not allow us to know the reasons for a low durability; absence or high cost of spare parts, difficulty of repair, etc., it does allow us to elaborate a ranking so that consumers can reward with their consumption choice, manufacturers who make products that reach high thresholds of durability.This work is partially supported by the Venture Builder program of the Ledger project of the European Commission #825268, the Agència de Residus de Catalunya, the Spanish government TIN2016-77836-C2-2R and the Catalan government AGAUR SGR 990. We thank the eReuse team, Xavier Bustamante, the developers of the smartmontools software, and the community of circular economy activists in eReuse, the Pangea circuit, and the open-source community in general, as metaphorically, we stand on the shoulders of giants that allow us to see beyond the horizon.Peer ReviewedPostprint (published version

Phase Structure, Compatibility, and Toughness of PLA/PCL Blends: A Review

Results of the studies dealing with the toughness of polylactic acid/polycaprolactone (PLA/PCL) blends are analyzed with respect to the PCL particle size, PLA matrix crystallinity, and presence of a compatibilizer. It is shown that a high toughness or even »super-toughness« of PLA/PCL blends without a compatibilizer can be achieved for blends with the proper size of PCL particles. Nevertheless, the window for obtaining the super-tough PLA/PCL blends is quite narrow, as the final impact strength is very sensitive to multiple parameters: namely the blend composition, PLA matrix crystallinity, and PCL particle size. Available literature data suggest that the optimal composition for PLA/PCL blends is around 80/20 (w/w). The PLA/PCL(80/20) blends keep high stiffness of PLA matrix and the concentration of PCL particles is sufficient to achieve high toughness. The PLA/PCL(80/20) blends with low-crystallinity PLA matrix (below ca 10 %) exhibit the highest toughness for bigger PCL particles (weight average diameter above 1 μm), while the blends with high-crystallinity PLA matrix (above ca 30 %) exhibit the highest toughness for smaller PCL particles (weight average diameter below 0.5 μm). The addition of a compatibilizer may improve the toughness only on condition that it helps to achieve a suitable particle size. The toughness of both non-compatibilized and compatibilized PLA/PCL blends with optimized morphology can be more than 15 times higher in comparison with neat PLA

Effect of suture technique on the occurrence of incisional hernia after elective midline abdominal wall closure: study protocol for a randomized controlled trial

Background: Based on a recent meta-analysis, a continuous suture technique with a suture to wound length ratio of at least 4: 1, using a slowly absorbable monofilament suture material, is recommended for primary median laparotomy closure. Incisional hernia, which develops in 9 to 20% of patients, remains the major complication of abdominal wall closure. Current clinical data indicate that the incidence of incisional hernias increases by 60% between the first and the third year after median laparotomy, implicating that a follow-up period of 1 year postoperatively is too short with regard to this common complication. Trauma to the abdominal wall can be reduced by improvements in suture technique as well as suture material. Several factors, such as stitch length, suture tension, elasticity, and tensile strength of the suture material are discussed and currently under investigation. A Swedish randomized controlled trial showed a significant reduction in the incisional hernia rate by shortening the stitch length. However, a non-elastic thread was used and follow-up ended after 12 months. Therefore, we designed a multicenter, international, double-blinded, randomized trial to analyze the influence of stitch length, using an elastic, extra-long term absorbable monofilament suture, on the long term clinical outcome of abdominal wall closure. Methods: In total, 468 patients undergoing an elective, median laparotomy will be randomly allocated to either the short stitch or the long stitch suture technique for abdominal wall closure in a 1: 1 ratio. Centers located in Germany and Austria will participate. The primary endpoint measure is the incisional hernia rate 1 year postoperatively, as verified by ultrasound. The frequency of short term and long term complications as well as costs, length of hospital stay and patients' quality of life (EQ-5D-5 L) will be considered as secondary parameters. Following hospital discharge, patients will be examined after 30 days and 1, 3, and 5 years after surgery. Discussion: This study will provide further evidence on whether a short stitch suture technique in combination with an elastic, extra-long term absorbable monofilament suture can prevent incisional hernias in the long term, compared with the long stitch suture technique

Infections associated with mesh repairs of abdominal wall hernias : Are antimicrobial biomaterials the longed-for solution?

The incidence of mesh-related infection after abdominal wall hernia repair is low, generally between 1 and 4%; however, worldwide, this corresponds to tens of thousands of difficult cases to treat annually. Adopting best practices in prevention is one of the keys to reduce the incidence of mesh-related infection. Once the infection is established, however, only a limited number of options are available that provides an efficient and successful treatment outcome. Over the past few years, there has been a tremendous amount of research dedicated to the functionalization of prosthetic meshes with antimicrobial properties, with some receiving regulatory approval and are currently available for clinical use. In this context, it is important to review the clinical importance of mesh infection, its risk factors, prophylaxis and pathogenicity. In addition, we give an overview of the main functionalization approaches that have been applied on meshes to confer anti-bacterial protection, the respective benefits and limitations, and finally some relevant future directions. (C) 2018 Elsevier Ltd. All rights reserved.Peer reviewe

Stromal vascular fraction cells as biologic coating of mesh for hernia repair

11 p.Background. The interest in non-manipulated cells originating from adipose tissue has raised tremendously in the field of tissue engineering and regenerative medicine. The resulting stromal vascular fraction (SVF) cells have been successfully used in numerous clinical applications. The aim of this experimental work is, first to combine a macroporous synthetic mesh with SVF isolated using a mechanical disruption process, and to assess the effect of those cells on the early healing phase of hernia. Methods. Human SVF cells combined with fibrin were used to coat commercial titanized polypropylene meshes. In vitro, viability and growth of the SVF cells were assessed using live/dead staining and scanning electron microscopy. The influence of SVF cells on abdominal wall hernia healing was conducted on immunodeficient rats, with a focus on short-term vascularization and fibrogenesis. Results. Macroporous meshes were easily coated with SVF using a fibrin gel as temporary carrier. The in vitro experiments showed that the whole process including the isolation of human SVF cells and their coating on PP meshes did not impact on the SVF cells? viability and on their capacity to attach and to proliferate. In vivo, the SVF cells were well tolerated by the animals, and coating mesh with SVF resulted in a decrease degree of vascularity compared to control group at day 21. Conclusions. The utilization of SVF-coated mesh influences the level of angiogenesis during the early onset of tissue healing. Further long-term animal experiments are needed to confirm that this effect correlates with a more robust mesh integration compared to non-SVF-coated mesh.European Hernia Society Research GrantTU

Update of Guidelines for laparoscopic treatment of ventral and incisional abdominal wall hernias (International Endohernia Society (IEHS)) : Part B

In 2014 the International Endohernia Society (IEHS) published the first international "Guidelines for laparoscopic treatment of ventral and incisional abdominal wall hernias". Guidelines reflect the currently best available evidence in diagnostics and therapy and give recommendations to help surgeons to standardize their techniques and to improve their results. However, science is a dynamic field which is continuously developing. Therefore, guidelines require regular updates to keep pace with the evolving literature. Methods For the development of the original guidelines all relevant literature published up to year 2012 was analyzed using the ranking of the Oxford Centre for Evidence-Based-Medicine. For the present update all of the previous authors were asked to evaluate the literature published during the recent years from 2012 to 2017 and revise their statements and recommendations given in the initial guidelines accordingly. In two Consensus Conferences (October 2017 Beijing, March 2018 Cologne) the updates were presented, discussed, and confirmed. To avoid redundancy, only new statements or recommendations are included in this paper. Therefore, for full understanding both of the guidelines, the original and the current, must be read. In addition, the new developments in repair of abdominal wall hernias like surgical techniques within the abdominal wall, release operations (transversus muscle release, component separation), Botox application, and robot-assisted repair methods were included. Results Due to an increase of the number of patients and further development of surgical techniques, repair of primary and secondary abdominal wall hernias attracts increasing interests of many surgeons. Whereas up to three decades ago hernia-related publications did not exceed 20 per year, currently this number is about 10-fold higher. Recent years are characterized by the advent of new techniques-minimal invasive techniques using robotics and laparoscopy, totally extraperitoneal repairs, novel myofascial release techniques for optimal closure of large defects, and Botox for relaxing the abdominal wall. Furthermore, a concomitant rectus diastasis was recognized as a significant risk factor for recurrence. Despite still insufficient evidence with respect to these new techniques it seemed to us necessary to include them in the update to stimulate surgeons to do research in these fields. Conclusion Guidelines are recommendations based on best available evidence intended to help the surgeon to improve the quality of his daily work. However, science is a continuously evolving process, and as such guidelines should be updated about every 3 years. For a comprehensive reference, however, it is suggested to read both the initially guidelines published in 2014 together with the update. Moreover, the presented update includes also techniques which were not known 3 years before

Chromatin mapping and single-cell immune profiling define the temporal dynamics of ibrutinib response in CLL

The Bruton tyrosine kinase (BTK) inhibitor ibrutinib provides effective treatment for patients with chronic lymphocytic leukemia (CLL), despite extensive heterogeneity in this disease. To define the underlining regulatory dynamics, we analyze high-resolution time courses of ibrutinib treatment in patients with CLL, combining immune-phenotyping, single-cell transcriptome profiling, and chromatin mapping. We identify a consistent regulatory program starting with a sharp decrease of NF-kappa B binding in CLL cells, which is followed by reduced activity of lineage-defining transcription factors, erosion of CLL cell identity, and acquisition of a quiescence-like gene signature. We observe patient-to-patient variation in the speed of execution of this program, which we exploit to predict patient-specific dynamics in the response to ibrutinib based on the pre-treatment patient samples. In aggregate, our study describes time-dependent cellular, molecular, and regulatory effects for therapeutic inhibition of B cell receptor signaling in CLL, and it establishes a broadly applicable method for epigenome/transcriptome-based treatment monitoring